[Federal Register Volume 84, Number 190 (Tuesday, October 1, 2019)]
[Notices]
[Pages 52134-52135]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-21320]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: Noramco Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before October 31, 2019. 
Such persons may also file a written request for a hearing on the 
application on or before October 31, 2019.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
request for hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on July 9, 2019, Noramco Inc., 500 Swedes Landing Road, 
Wilmington, Delaware 19801-4417 applied to be registered as an importer 
of the following basic classes of controlled substances:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Marihuana...............................   7360  I
Tetrahydrocannabinols...................   7370  I
Nabilone................................   7379  II
Phenylacetone...........................   8501  II
Opium, raw..............................   9600  II
Poppy Straw Concentrate.................   9670  II
Tapentadol..............................   9780  II
------------------------------------------------------------------------

    The company plans to import phenylacetone (8501), and poppy straw 
concentrate (9670) to bulk manufacture other controlled substances for 
distribution to its customers. In reference to drug codes 7360 
(marihuana) and 7370 (THC), the company plans to import a synthetic 
cannabidiol and a synthetic tetrahydrocannabinol. No other activity for 
these drug codes is authorized for this registration. Placement of 
these drug codes onto the company's registration does not translate 
into automatic approval of subsequent permit applications to import 
controlled substances.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import 
of FDA approved or non-approved finished dosage forms for commercial 
sale.


[[Page 52135]]


    Dated: September 23, 2019.
Thomas W. Prevoznik,
Acting Assistant Administrator, Deputy Assistant Administrator.
[FR Doc. 2019-21320 Filed 9-30-19; 8:45 am]
 BILLING CODE 4410-09-P